273 related articles for article (PubMed ID: 5527165)
1. The neuroleptics. 3. Pharmacology. Introduction.
Van Rossum JM; Janssen PA; Boissier JR; Julou L; Loew DM; Moller Nielsen I; Munkvad I; Randrup A; Stille G; Tedeschi DH
Mod Probl Pharmacopsychiatry; 1970; 5():23-32. PubMed ID: 5527165
[No Abstract] [Full Text] [Related]
2. Chemical and pharmacological classification of neuroleptics.
Janssen PA
Mod Probl Pharmacopsychiatry; 1970; 5():33-44. PubMed ID: 5535847
[No Abstract] [Full Text] [Related]
3. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
Randrup A
Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
[No Abstract] [Full Text] [Related]
4. Definition and classification of neuroleptics.
Arnold OH; Collard J; Deniker P; Ginestet D; Hippius H; Itil TM; Labhardt F; Leeds AA; Montanini R; Morozov G; Simon P; Villeneuve A
Mod Probl Pharmacopsychiatry; 1970; 5():141-7. PubMed ID: 5527163
[No Abstract] [Full Text] [Related]
5. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ
Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815
[No Abstract] [Full Text] [Related]
6. The neuroleptics. 5. Animal behavior.
Buser P; Cook L; Giurgea C; Jacobsen E; Ray OS; Richelle M; Silverman AP; Stein L; Votava Z
Mod Probl Pharmacopsychiatry; 1970; 5():85-108. PubMed ID: 5005610
[No Abstract] [Full Text] [Related]
7. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
Khisti RT; Deshpande LS; Chopde CT
Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
[TBL] [Abstract][Full Text] [Related]
8. Neurophysiological substrates of the pharmacological criteria for neuroleptics.
Stille G
Mod Probl Pharmacopsychiatry; 1970; 5():56-60. PubMed ID: 5527169
[No Abstract] [Full Text] [Related]
9. Methods for evaluation of long acting neuroleptic drugs in animals.
Kazdová E; Dlabac A; Metysová J
Act Nerv Super (Praha); 1972; 14(2):126-7. PubMed ID: 5064759
[No Abstract] [Full Text] [Related]
10. On the interaction between neuroleptics and antiparkinson drugs.
Julou L
Mod Probl Pharmacopsychiatry; 1970; 5():50-4. PubMed ID: 5527168
[No Abstract] [Full Text] [Related]
11. Is dopamine antagonism a requisite of neuroleptic activity?
Greenblatt EN; Coupet J; Rauh E; Szucs-Myers VA
Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):105-19. PubMed ID: 6111298
[TBL] [Abstract][Full Text] [Related]
12. Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.
Niemegeers CJ; Janssen PA
Arzneimittelforschung; 1974 Jan; 24(1):45-52. PubMed ID: 4406109
[No Abstract] [Full Text] [Related]
13. Antagonism by neuroleptics of abnormal behavior induced by activation of brain dopamine receptors.
Van Rossum JM
Mod Probl Pharmacopsychiatry; 1970; 5():65-7. PubMed ID: 5527171
[No Abstract] [Full Text] [Related]
14. Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Wauquier A
Arzneimittelforschung; 1975 Aug; 25(8):1287-94. PubMed ID: 1242360
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of neuroleptics upon repeated administration.
Moller Nielsen I; Fjalland B; Pedersen V; Nymark M
Psychopharmacologia; 1974 Jan; 34(2):95-104. PubMed ID: 4856370
[No Abstract] [Full Text] [Related]
16. Pharmacology and physiology of stereotyped behavior.
Randrup A; Munkvad I
J Psychiatr Res; 1974; 11():1-10. PubMed ID: 4218871
[No Abstract] [Full Text] [Related]
17. Pharmacology and biochemistry of haloperidol.
Niemegeers CJ; Laduron PM
Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):3-8. PubMed ID: 14331
[No Abstract] [Full Text] [Related]
18. The prediction of sedative potency of neuroleptics.
Loew DM
Mod Probl Pharmacopsychiatry; 1970; 5():47-50. PubMed ID: 5527167
[No Abstract] [Full Text] [Related]
19. [Central effects of some adreno- and-or sympatholytic substances. 3. Ptosis, catalepsy, antagonism with respect to apomorphine and amphetamine].
Boissier JR; Simon P; Giudicelli JF
Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):68-80. PubMed ID: 5689547
[No Abstract] [Full Text] [Related]
20. [Effect of hydroxyzine and oxylidine on the central nervous system].
Novikova GV; Komendantova MV
Farmakol Toksikol; 1971; 34(2):131-5. PubMed ID: 4397903
[No Abstract] [Full Text] [Related]
[Next] [New Search]
